Loading...
XSHG
600064
Market cap2.07bUSD
Oct 09, Last price  
7.99CNY
1D
-0.37%
1Q
9.15%
Jan 2017
6.82%
Name

Nanjing Gaoke Co Ltd

Chart & performance

D1W1MN
XSHG:600064 chart
P/E
7.55
P/S
4.04
EPS
1.06
Div yield, %
3.74%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
3.18%
Revenues
3.42b
+72.61%
1,693,452,1461,076,093,0941,518,368,0812,110,050,3512,681,485,2152,431,210,3062,178,214,1733,528,974,8603,285,599,3443,882,241,7715,220,806,4743,626,072,0713,424,537,2792,930,211,2462,923,501,1494,934,526,8854,490,060,5944,733,038,0241,980,256,9353,418,217,404
Net income
1.83b
+6.09%
100,326,463162,918,806191,927,939255,575,519314,129,244364,910,906383,809,261430,469,708609,779,805848,201,709926,527,965946,024,729958,359,3631,842,037,9482,015,788,6112,352,053,0592,402,373,8161,560,145,8731,725,229,8951,830,225,541
CFO
981m
P
244,872,17300612,369,58300377,537,989909,801,9751,268,250,1051,719,100,2822,107,885,100184,210,462464,626,6961,175,032,4340501,491,2720-1,322,978,947-500,820,614980,519,893
Dividend
Jul 17, 20260.32 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Nanjing, China, in 1992, Nanjing Gaoke Company Limited operates as a diversified enterprise with its core business centered on real estate development, particularly commercial and residential properties across China. The company's extensive operations also encompass significant infrastructure projects, including community revitalization, the construction of new roads, and the development of mountain parks. It provides a comprehensive range of construction and engineering services, such as residential building, municipal engineering (including supervision), landscaping, wastewater treatment, and water utility provisions. Additionally, the firm offers property management, land utilization planning, architectural and engineering design, and environmental protection project implementation. Beyond these activities, Nanjing Gaoke is actively engaged in a broad spectrum of investment ventures, including industrial investment, venture capital, securities trading, and offering investment management and consulting. A key part of its financial services includes providing financing support to small and medium-sized technology firms and emerging startups. Further diversifying its portfolio, the company manufactures and distributes both traditional Chinese and Western pharmaceutical preparations, offers medical and healthcare advisory services, and provides property leasing options.

Key people

Kejin Zhou
Chief Financial Officer · since 2016
Zhao Guo
Vice President · since 2013
Chen Lu
Vice President · since 2009
Yangjun Lu
Vice President · since 2016
Jianhui Xie
Secretary of the Board · since 2010
Chairman of the Board · since 2013
Independent Director
Independent Director · since 2009
IPO date
May 06, 1997
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
南京经济技术开发区恒通大道2号
南京市, JS 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT